Low Philip S
SEC CIK 1509669 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | Dir | 455.3K | — | — | 2 | 2022-05-19 | 2022-05-19 |
Most active insiders at QNCX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Benatti Luca | Dir | — | $173.5K |
| 2 | Hannah Brendan | COO, CCO, CBO | — | — |
| 3 | Thye Dirk | CEO, CMO, Dir | — | — |
Low Philip S made no open-market trades at QNCX in the last 12 months.
Transactions 2
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-05-23 | 2022-05-19 | QNCX | Quince Therapeutics, Inc. | Low Philip S | Dir | A - Grant | — | +455.3K | 455.3K | New | — |
| DI | 2022-05-23 | 2022-05-19 | QNCX | Quince Therapeutics, Inc. | Low Philip S | Dir | A - Grant | — | +64.0K | 64.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations